Patent ID: 11866505
Assignee: PROMETHEUS BIOSCIENCES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The antibody or antigen binding fragment thereof of claim 1, wherein the CDR-H1 comprises the amino acid sequence set forth in SEQ ID NO: 116, the CDR-H2 comprises the amino acid sequence set forth in SEQ ID NO: 156, the CDR-H3 comprises the amino acid sequence set forth in SEQ ID NO: 196, the CDR-L1 comprises the amino acid sequence set forth in SEQ ID NO: 316, the CDR-L2 comprises the amino acid sequence set forth in SEQ ID NO: 356, and the CDR-L3 comprises the amino acid sequence set forth in SEQ ID NO: 396.